Scapa Healthcare to acquire Systagenix wound dressing facility in UK

Scapa Healthcare has signed an agreement to purchase the Systagenix manufacturing facility in Gargrave, England from Acelity. The 335,000-square-foot site will be transferred to Scapa Healthcare along with a long-term manufacturing and supply agreement for advanced wound dressings.

“This technology transfer is in line with our growth strategy, and we are excited about the opportunities this facility brings as we continue to expand our portfolio of turn-key solutions.”scapahealthcare.com

• 1 source
• scapahealthcare.comScapa Healthcare Enters Agreement to Acquire Advanced Wound Dressing Facility in the UKSep 13, 2018

Summarized from public sources; check the original articles before acting on it.